Increased life expectancy is leading to a rise in the geriatric population across the region. According to the World Population Ageing 2017 report of the United Nations, in 2017, Europe had the highest percentage (25%) of people over the age of 60. According to the National Center for Biotechnology Information, the prevalence of chronic pain among the elderly population worldwide is estimated to be 25–85%. The rise in the elderly population has led to an increase in geriatric ailments. The rising incidence of illness in the geriatric population is propelling the demand for convenience-driven personal therapeutic devices, such as photobiostimulation devices, for pain management. Thus, the rapid growth in the geriatric population bolsters the growth of the Europe medical photobiostimulation systems market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the medical photobiostimulation system market at a promising CAGR during the forecast period.
TheEurope medical photobiostimulation system marketis segmented into product and application. Based on product, the market is segmented into infrared light, red light, and others. Based on application, the market is segmented into pain management, wound care, cosmetic applications, and others. Geographically, the Europe medical photobiostimulation system market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe.
BioLight Technologies LLC., Omega Laser Systems Ltd, Vielight Inc., Theradome Inc., Lexington Intl., LLC, THOR Photomedicine Ltd, Meditech International Inc. (BIOFLEX Laser Therapy), and Apira Science, Inc. (iGrow Laser) are among the leading companies in the Europe medical photobiostimulation system market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 52.6 Million |
| Market Size by 2028 | US$ 78.4 Million |
| CAGR (2021 - 2028) | 5.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Medical Photobiostimulation System Market is valued at US$ 52.6 Million in 2021, it is projected to reach US$ 78.4 Million by 2028.
As per our report Europe Medical Photobiostimulation System Market, the market size is valued at US$ 52.6 Million in 2021, projecting it to reach US$ 78.4 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.
The Europe Medical Photobiostimulation System Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Medical Photobiostimulation System Market report:
The Europe Medical Photobiostimulation System Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Medical Photobiostimulation System Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Medical Photobiostimulation System Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Medical Photobiostimulation System Market
